brimonidine topical rosacea
Selected indexed studies
- Rosacea management: A comprehensive review. (J Cosmet Dermatol, 2022) [PMID:35104917]
- Rosacea. (Br J Hosp Med (Lond), 2021) [PMID:33646026]
- S2k guideline: Rosacea. (J Dtsch Dermatol Ges, 2022) [PMID:35929658]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Neurogenic Rosacea Treatment: A Literature Review. (2023) pubmed
- Rosacea. (2021) pubmed
- Rosacea management: A comprehensive review. (2022) pubmed
- S2k guideline: Rosacea. (2022) pubmed
- Spotlight on brimonidine topical gel 0.33% for facial erythema of rosacea: safety, efficacy, and patient acceptability. (2017) pubmed
- Rosacea: Diagnosis and Treatment. (2015) pubmed
- Topical brimonidine for the management of facial erythema in rosacea: a histological, histometric, and immunohistochemical study. (2023) pubmed
- Rosacea: An Update in Diagnosis, Classification and Management. (2021) pubmed
- Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments. (2019) pubmed
- Dermatological Adverse Events Associated with Topical Brimonidine Gel 0.33% in Subjects with Erythema of Rosacea: A Retrospective Review of Clinical Studies. (2015) pubmed